As of May 2026, 10 statesAlabama, California, Florida, Louisiana, Missouri, North Carolina, Ohio, Tennessee, Texas, and Utahhad new congressional maps
The good news, as a recent study published in Menopause journal confirmed, is that perimenopause is actually the period when your metabolism is most flexible and most responsive to these changes
Tirzepatide is a novel agent that acts as an agonist for both GLP-1 receptors and gastric inhibitory polypeptide (GIP) receptors, another incretin that lowers glucose and appetite
1 2 3 4 "Highlights From the New ACG Clinical Guideline for Gastroparesis"
Growing evidence has suggested that GLP-1 RAs may affect patients mood, leading to anxiety, depression, and even suicidal tendencies
Disclaimer: This article is educational